These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9145713)

  • 21. Remember beta-blockers for older MI patients. Study: 21% of eligible patients receive treatment.
    Hosp Case Manag; 1997 Feb; 5(2):32-3. PubMed ID: 10164829
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug treatment following an infarction].
    Lasserre B; Périat M
    Rev Med Suisse Romande; 1994 Aug; 114(8):677-81. PubMed ID: 7939090
    [No Abstract]   [Full Text] [Related]  

  • 23. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
    Setoguchi S; Glynn RJ; Avorn J; Levin R; Winkelmayer WC
    Am J Cardiol; 2007 Oct; 100(7):1061-7. PubMed ID: 17884362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.
    Krumholz HM; Radford MJ; Wang Y; Chen J; Heiat A; Marciniak TA
    JAMA; 1998 Aug; 280(7):623-9. PubMed ID: 9718054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug prescription in myocardial postinfarction: results of the EPPI (étude de prescription postinfarctus). A French cooperative study].
    Boissel JP; Némoz C; Gillet J; Salewski B; Diaz N
    Arch Mal Coeur Vaiss; 1990 Nov; 83(12):1777-82. PubMed ID: 1980055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-blockers after acute myocardial infarction in elderly patients with diabetes mellitus: time to reassess.
    Di Bari M; Marchionni N; Pahor M
    Drugs Aging; 2003; 20(1):13-22. PubMed ID: 12513113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-blockers underutilized.
    Tracy GE
    S D J Med; 2001 May; 54(5):185. PubMed ID: 11392204
    [No Abstract]   [Full Text] [Related]  

  • 29. Reducing post-myocardial infarction mortality in the elderly: the power and promise of secondary prevention.
    Boden WE; Maron DJ
    J Am Coll Cardiol; 2008 Apr; 51(13):1255-7. PubMed ID: 18371554
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcomes of inappropriate prescribing of beta-blockers after an acute myocardial infarction in a Medicaid population.
    Fernandes AW; Madhavan SS; Amonkar MM; Bell D; Islam SS; Scott VG
    Ann Pharmacother; 2005 Sep; 39(9):1416-22. PubMed ID: 15972326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current utilization trends for beta-blockers in cardiovascular disease.
    Kennedy HL
    Am J Med; 2001 Apr; 110 Suppl 5A():2S-6S. PubMed ID: 11259750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A slow trickledown. Data on efficacy of beta blockers belatedly spur use.
    Moore JD
    Mod Healthc; 1998 Sep; 28(37):70. PubMed ID: 10183097
    [No Abstract]   [Full Text] [Related]  

  • 33. A vital drug for heart attack patients.
    Johns Hopkins Med Lett Health After 50; 1998 Feb; 10(12):1-2. PubMed ID: 9916578
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of postmyocardial infarction in the elderly patient.
    Forman R; Aronow WS
    Clin Geriatr Med; 1996 Feb; 12(1):169-80. PubMed ID: 8653656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-blocker use in patients with acute myocardial infarction treated by hospitalists.
    Dall L; Simmons T; Peterson S; Herndon B
    Manag Care Interface; 2000 May; 13(5):61-3, 69. PubMed ID: 11067397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O; Welten GM; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
    Fernandes AW; Madhavan SS; Amonkar MM
    Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of anti-ischemia treatment in man].
    Dupuis B; Vincent A; Lablanche JM
    Arch Mal Coeur Vaiss; 1987 Dec; 80 Spec No():73-6. PubMed ID: 2895620
    [No Abstract]   [Full Text] [Related]  

  • 39. Prescribing pattern of angiotensin- converting enzyme inhibitors and beta blockers after acute myocardial infarction.
    Sweileh WM; Shkokani FM; Sawalha AF; Al-Ramahi RJ; Jaradat NA; Zaid AA; Barakat AS
    Saudi Med J; 2005 Nov; 26(11):1837-9. PubMed ID: 16311686
    [No Abstract]   [Full Text] [Related]  

  • 40. Beta-blockers are poorly tolerated by the elderly: myth or reality?
    Cooper JW
    Postgrad Med; 2002 Dec; 112(6 Suppl Heart):12-20. PubMed ID: 19667613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.